Skip Navigation
Skip to contents

ICoLA 2021

Today : 2021.04.21
D- 142
Please fill out the following form to contact
the ICoLA 2021 secretariat.
contact us

닫기

Scientific Program

  • HOME
  • Program
  • Scientific Program

BREAKFAST SYMPOSIUM 4
Sep.11(Sat.)
08:00 - 09:00
Room 1
BREAKFAST SYMPOSIUM 5
Sep.11(Sat.)
08:00 - 09:00
Room 2
BREAKFAST SYMPOSIUM 6
Sep.11(Sat.)
08:00 - 09:00
Room 3
PLENARY LECTURE 4
Sep.11(Sat.)
09:00 - 09:30
Room 1+2+3
TG metabolism and apoC-ll-based therapeutics Alan Remaley (National Institute of Health, USA)
BREAK
Sep.11(Sat.)
09:30 - 09:40
All
SYMPOSIUM 14 Recent studies on PCSK9 inhibitors & omega-3 PUFA
Sep.11(Sat.)
09:40 - 11:20
Room 1
09:40-10:05 Latest data on siRNA against PCSK9
10:05-10:30 Patient selection for PCSK9 MAb therapies Kausik Ray (Imperial Callege London, UK)
10:30-10:55 Biological effect & clinical benefit of omega-3 PUFA
10:55-11:20 Discussion
SYMPOSIUM 15 New treatment agents for dyslipidemia
Sep.11(Sat.)
09:40 - 11:20
Room 2
09:40-10:05 Antisenseoligonucleotide in treatment of dyslipidemia
10:05-10:30 TBD
10:30-10:55 New PPARalpha agonist Sang Yong Kim (Chosun University, Korea)
10:55-11:20 Discussion
SYMPOSIUM 16 Update on lipoprotein metabolism & regulation
Sep.11(Sat.)
09:40 - 11:20
Room 3
09:40-10:05 Latest studies on TG-rich lipoprotein metabolism Jenny E. Kanter (University of Washington, USA)
10:05-10:30 What's new in intracellular lipid trafficking Young Mi Park (Ewha Womans University, Korea)
10:30-10:55 Regulation of TG transfer protein in lipid metabolism Mahmood Hussain (New York University, USA)
10:55-11:20 Discussion
SYMPOSIUM 17 What’s new in lifestyle/nutrition modification
Sep.11(Sat.)
09:40 - 11:20
Room 4
09:40-10:05 Lifestyle risk score and mortality: a population-based cohort study
10:05-10:30 Lifestyle modification: tech-based, behavior-based, & personalized nutrition
10:30-10:55 Nutrition policies to improve diet and reduce health and economic burdens of cardiometabolic diseases: a microsimulation study Yujin Lee (Myongji University, Korea)
10:55-11:20 Discussion
SYMPOSIUM 18 Update on platelet in atherosclerosis & acute coronary syndrome
Sep.11(Sat.)
09:40 - 11:20
Room 5
09:40-10:05 Update on pathophysiology of acute coronary syndrome
10:05-10:30 Recent studies on platelets in atherosclerosis & thrombosis
10:30-10:55 Latest therapeutic strategies to modify platelet function Soon Jun Hong (Korea University, Korea)
10:55-11:20 Discussion
COFFEE BREAK
Sep.11(Sat.)
11:20 - 11:40
All
PLENARY LECTURE 5
Sep.11(Sat.)
11:40 - 12:10
Room 1+2+3
Genetics/epigenetic approach in studies of lipid metabolism & atherosclerosis Kiran Musunuru (University of Pennsylvania, USA)
LUNCHEON SYMPOSIUM 5
Sep.11(Sat.)
12:10 - 13:10
Room 1
LUNCHEON SYMPOSIUM 6
Sep.11(Sat.)
12:10 - 13:10
Room 2
LUNCHEON SYMPOSIUM 7
Sep.11(Sat.)
12:10 - 13:10
Room 3
LUNCHEON SYMPOSIUM 8
Sep.11(Sat.)
12:10 - 13:10
Room 4
ORAL PRESENTATION 3
Sep.11(Sat.)
13:10 - 14:10
Room 4
ORAL PRESENTATION 4
Sep.11(Sat.)
13:10 - 14:10
Room 5
PLENARY LECTURE 6
Sep.11(Sat.)
14:10 - 14:40
Room 1+2+3
Targeting smooth muscle cell in management of ASCVD Gary Owens (University of Virginia, USA)
COFFEE BREAK
Sep.11(Sat.)
14:40 - 15:00
All
SYMPOSIUM 19 Targeting Lp(a) & inflammation in ASCVD
Sep.11(Sat.)
15:00 - 16:40
Room 1
15:00-15:25 Lp(a) as a risk factor Hiroshi Yoshida (Jikei University School of Medicine, Japan)
15:25-15:50 Recent results on Lp(a) therapeutics
15:50-16:15 Anti-inflammatory treatment to reduce CV risk Jung Ho Heo (Kosin University, Korea)
16:15-16:40 Discussion
SYMPOSIUM 20 Current & future treatment for HeFH & HoFH
Sep.11(Sat.)
15:00 - 16:40
Room 2
15:00-15:25 Future of CV risk stratification in FH patients Hayato Tada (Kanazawa University, Japan)
15:25-15:50 Current trend in treatment of HeFH/HoFH Dirk Blom (Hatter Institute for Cardiovascular Research in Africa, South Africa)
15:50-16:15 Upcoming treatment agents for FH Sang-Hyun Kim (Seoul National University, Korea)
16:15-16:40 Discussion
SYMPOSIUM 21 HDL update
Sep.11(Sat.)
15:00 - 16:40
Room 3
15:00-15:25 Beyond HDL-cholesterol: the search for functional biomarkers of HDL Arnold von Eckardstein (University of Zürich, Switzerland)
15:25-15:50 Update on the structure & function of HDL Tomas Vaisar (University of Washington, USA)
15:50-16:15 What's new in HDL-modifying therapeutics?
16:15-16:40 Discussion
SYMPOSIUM 22 Role of noncoding RNA in lipid metabolism & vascular disease
Sep.11(Sat.)
15:00 - 16:40
Room 4
15:00-15:25 Recent studies on miRNA in lipid metabolism & atherosclerosis Koh Ono (Kyoto University, Japan)
15:25-15:50 Non-coding RNA control of cholesterol metabolism and atherosclerosis Katey Rayner (University of Ottawa, Canada)
15:50-16:15 The role of non-coding RNAs in vascular smooth muscle cells Young-Kook Kim (Chonnam National University, Korea)
16:15-16:40 Discussion
PUBLICATION COMMITTEE SESSION
Sep.11(Sat.)
15:00 - 16:40
Room 5
BREAK
Sep.11(Sat.)
16:40 - 16:50
All
CLOSING CEREMONY
Sep.11(Sat.)
16:50 -
All
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Donghoon Choi

Secretariat of ICoLA 2021 │ People & Value, Inc.

#A-1108, Doosan The Land Park, 161-8, Magokjungang-ro, Gangseo-gu, Seoul, Republic of Korea

Copyrights 2021 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.